This MIKAIA® app note demonstrates how to analyze a 47-plex spatial proteomics scan created with MACSima ™ (by Miltenyi Biotec), utilizing sequential immunofluorescence for the analysis: Instrument: MACSima™ by Miltenyi...
Researchers at the Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM) have developed PEDRA: Platform for Ex-Vivo Drug Response Assays. Up to 100 compounds are tested in parallel on primary patient...
The MIKAIA® Cellular Neighborhood App can yield statistics about the cellular microenvironment, i.e., identify cell niches or cellular communities. This presents a type of spatial analysis of cell populations detected...
The Laboratory for Bio-Micro Devices at Brigham and Women’s Hospital () develops drug releasing implantable intratumoral microdevices (IMD) [1]. Using MIKAIA®, they want to examine in a quantitative fashion how...
CODEX, now called PhenoCycler, by Akoya Biosciences, along with other sequential immunofluorescence technologies (e.g., Lunaphore (Comet), Miltenyi Biotech (MACSima), Leica Microsystems (Cell DIVE), or other vendors)...
MIKAIA® University is the central MIKAIA® learning portal. Here you can find various App Notes and Video Tutorials that describe typical MIKAIA® workflows either from a technical or medical perspective. As we are...
This app note describes the MIKAIA Plugin API. It can be used by bioinformaticians to plug in their own AI script, e.g., written in Python or any other language, into MIKAIA® and this way put their AI into the hands of...
MIKAIA® is specifically designed for researchers in academia, CROs, biotech, pharma. One of the challenges is that researchers by design do unique things. For this reason, MIKAIA® apps do not represent individual side...